VEXAS SYNDROME
Clinical trials for VEXAS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VEXAS SYNDROME trials appear
Sign up with your email to follow new studies for VEXAS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new drug trial for rare inflammatory disease VEXAS
Disease control Not yet recruitingThis study tests a drug called momelotinib in 192 adults with VEXAS syndrome, a rare and serious inflammatory condition caused by a genetic mutation. The goal is to see if the drug can reduce disease activity, with participants receiving either momelotinib or a placebo. The trial…
Matched conditions: VEXAS SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 05:52 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: VEXAS SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC